Prime Peptides
$60.00- Price / mg
- $6.00
- Document access
- Public link
$9.95 US; free over $150
Research price index / 10 mgTesamorelin 10 mg
Fast comparison 01 02
Tesamorelin 10 mg
price comparison.
Five public US 10 mg laboratory-research listings compared on nominal size, availability language, unit price, seller document access, and checked date.
Current answer. As of Jul 23, 2026, 4 confirmed in-stock listings run from $60.00 to $79.19, with a $73.00 median across the in-stock rows. All 5 seller pages remain visible below.
Start with the two lowest confirmed in-stock rows.
5/5 current price and availability signals rechecked July 28, 2026 at 4:47 PM UTC.Pure Health Peptides
$73.00- Price / mg
- $7.30
- Document access
- Public link
Free shipping over $175; lower-order rate at checkout
A list-price starting point, not a product-quality, safety, or seller recommendation.
Growth-signaling analoguesEgriftaTH9507
In-stock from$60.00
In-stock high$79.19
Spread32%
CheckedJul 23
Price and evidence decision lens
Three numbers before a source click.
List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Prime Peptides
$9.95 US; free over $150
Open vendor evidence profile →Prime Peptides
Report displayed. Access is public, but authenticity and custody are not established.
Inspect transparency record →Same lowest row
This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Prime Peptides row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter Tesamorelin vendors by stock, price, and public documents →Laboratory research category.Not an approved product for human use, medical treatment, or veterinary use.
5/5 rows shown
Commercial-link disclosure: we may earn a commission after a click. Placement does not change price rank. Seller testing claims are labeled, not treated as our own verification.
Current board4 of 5 in stockAvailable list range $60.00–$79.19
Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsCustom comparisonChoose two rows for a landed-cost check.Select any two seller rows. The calculator carries over list price and nominal milligrams, then lets you add shipping and mandatory fees.
0 / 2 selected
Select 2 more rowsLatest source recheck5/5current price and availability signals confirmed
Checked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 10 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Prime PeptidesLowest in-stock list priceIn stock | $60.00Source confirmed | $6.00 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
02Pure Health PeptidesPrice and stock confirmed Jul 27In stock | $73.00Source confirmed | $7.30 | Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026 | Free shipping over $175; lower-order rate at checkout | |
03Biotech PeptidesPublic size-specific documentsIn stock | $73.00Source confirmed | $7.30 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
04Pepta LabsFree shipping claimedIn stock | $79.19Source confirmed | $7.92 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
05Core PeptidesPrice shown; stock label absentStatus not stated | $79.00Source confirmed | $7.90 | COA tab shownAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
01$60.00
Prime Peptides
Lowest in-stock list price · In stock- Per mg
- $6.00
- Evidence
- Report displayedPublic link
- Shipping
- $9.95 US; free over $150
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 02$73.00
Pure Health Peptides
Price and stock confirmed Jul 27 · In stock- Per mg
- $7.30
- Evidence
- Public lot COA libraryPublic link
- Shipping
- Free shipping over $175; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 03$73.00
Biotech Peptides
Public size-specific documents · In stock- Per mg
- $7.30
- Evidence
- COA, LC, and MS imagesPublic link
- Shipping
- Free USPS Priority over $200; lower-order rate not stated
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 04$79.19
Pepta Labs
Free shipping claimed · In stock- Per mg
- $7.92
- Evidence
- COA on requestOn request
- Shipping
- Free US shipping claimed
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 05$79.00
Core Peptides
Price shown; stock label absent · Status not stated- Per mg
- $7.90
- Evidence
- COA tab shownPublic link
- Shipping
- Free over $200; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record 1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Exact-listing document checkpoints
A COA is not one check.
Start with how the document can be reached, then match it to this exact Tesamorelin 10 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
Prime Peptides
Report displayedThe public product page displays a third-party report for a 10 mg listing. Peptide Local recorded the report route without verifying chain of custody or vial contents.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 23, 2026
Pepta Labs
COA on requestSeller states independent HPLC purity and ESI-MS identity testing with a batch certificate available on request. Peptide Local did not sample the material.
- First action
- Request before relying
- First check
- Ask for the exact current-lot report, its date, analytical methods, and a laboratory verification route.
- Source checked
- Jul 23, 2026
Pure Health Peptides
Public lot COA libraryThe exact 10 mg variation was purchasable and the seller links its public batch-document library. Peptide Local did not authenticate the represented lot, custody, or vial contents.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 27, 2026
Biotech Peptides
COA, LC, and MS imagesThe seller page exposes separate 10 mg COA, liquid-chromatography, and mass-spectrometry images. Peptide Local verified the public document route, not chain of custody or vial contents.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 23, 2026
Core Peptides
COA tab shownThe 10 mg option and certificate-of-analysis tab were visible on the public page. No separate stock label was captured, and the material was not independently sampled.
- First action
- Inspect before relying
- First check
- Match the exact compound, nominal size, lot or batch identifier, report date, and named laboratory.
- Source checked
- Jul 23, 2026
Use the same ten fields every time.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
Provider matchups for this board
Compare sellers without losing the Tesamorelin row.
These canonical matchups open directly on the Tesamorelin 10 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Pepta LabsvsPrime Peptides
- Pepta Labs
- $79.19In stock
- Prime Peptides
- $60.00In stock
Prime Peptides is $19.19 lower before shipping.
- DocumentsOn request / Public link
- Source recheck16/16 / 9/9
Prime PeptidesvsBiotech Peptides
- Prime Peptides
- $60.00In stock
- Biotech Peptides
- $73.00In stock
Prime Peptides is $13.00 lower before shipping.
- DocumentsPublic link / Public link
- Source recheck9/9 / 12/12
Prime PeptidesvsPure Health Peptides
- Prime Peptides
- $60.00In stock
- Pure Health Peptides
- $73.00In stock
Prime Peptides is $13.00 lower before shipping.
- DocumentsPublic link / Public link
- Source recheck9/9 / 8/8
Pepta LabsvsBiotech Peptides
- Pepta Labs
- $79.19In stock
- Biotech Peptides
- $73.00In stock
Biotech Peptides is $6.19 lower before shipping.
- DocumentsOn request / Public link
- Source recheck16/16 / 12/12
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
Dated price history / 2026-07-21
Pepta Labs changed this exact 10 mg row.
The public list price moved from $71.99 in Peptide Local's 2026-07-17 snapshot to $79.19 after four matching source checks. That is a $7.20 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 4 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete Tesamorelin price history →Open the full peptide price change record →Category context
Keep the category boundary visible.
Tesamorelin is also the proper name of FDA-licensed Egrifta products. Those prescription biologics have specific strengths, indications, labeling, and regulated supply chains; the laboratory research listings on this page are not Egrifta and are not approval-equivalent.
Check the FDA Purple Book product record ↗Identity, evidence, and worldwide status
Tesamorelin decision map.
Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 20265US price records
4confirmed in stock
3in-stock public document routes
42country verification guides
2country-specific status findings
US research-market identity with a separate FDA-licensed medicine record
This record resolves seller-labelled 10 mg tesamorelin research listings. EGRIFTA WR is a separate FDA-licensed prescription product with a specific application, 11.6 mg presentation, indication, label, and regulated supply chain. The research listings do not inherit that approval.
Check the FDA Purple Book product recordU.S. Food and Drug Administration, Purple Book↗5 exact-size seller records
The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row4 currently confirmed in stock↓Run the exact intervention search
Tesamorelin is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search Tesamorelin on ClinicalTrials.govLive official registry route, not a cached result count↗42 countries across 5 regions
The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 2 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗Compound-specific country evidence2 current country findings with their boundaries
A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
Research listing separated from FDA-licensed EGRIFTA WR
EGRIFTA WR is an FDA-licensed tesamorelin prescription product under BLA 022505, with an 11.6 mg presentation and a defined HIV-lipodystrophy indication. The 10 mg research listings tracked here are not EGRIFTA WR, do not share its label, and do not inherit its approval or supply chain.
Named in a Health Canada unauthorized product seizure
Health Canada records a seller-labelled 10 mg tesamorelin product among unauthorized health products seized from a Canadian business. That record does not establish the status or identity of every tesamorelin listing, and it does not transfer the US EGRIFTA WR approval to a research vial.
What this page can tell you
The public commercial snapshot.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
What it cannot tell you
What is actually in a vial.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Tesamorelin price comparison FAQ
Direct answers with the trade-offs attached.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
What is the lowest current Tesamorelin 10 mg price?
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $60.00 from Prime Peptides. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
Which Tesamorelin listings have public document access?
3 confirmed in-stock rows link to a public seller document route: Prime Peptides, Pure Health Peptides, Biotech Peptides. The lowest of those rows is Prime Peptides at $60.00. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
Does the lowest Tesamorelin price include shipping?
No. The board compares public single-unit list prices for the same 10 mg nominal size. The current lowest row states: $9.95 US; free over $150. Use the landed-cost calculator before treating the list-price order as the final order cost.
What should I check before buying a seller-labelled Tesamorelin research listing?
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
How do I check a Tesamorelin COA or laboratory report?
Start by matching the exact Tesamorelin identity and 10 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
Related peptide comparisons
Keep Tesamorelin in the right row.
These pair guides compare research-market identity, exact board size, seller overlap, price footprint, and evidence access. They do not rank effects or recommend personal use.
Country, state & city context
Check the market route where you are.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.